Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Comorbidities in Heart Failure: What Could Be Done Better?
ESC 365 is supported by
